Our current study shows that the efficacy of ADI-PEG 20 was enhanced in combination with NAC, suggesting that the combination of ADI-PEG 20, NAC, and anti-PD-1/PD-L1 blockade may be a promising therapeutic approach for the treatment of cancers. This evidence concerns the gene CD274 and cancer.